<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study utilized middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) with tissue plasminogen activator (tPA) to assess inhibition of the NOX2 isoform of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase on brain injury and functional recovery in aged rats </plain></SENT>
<SENT sid="1" pm="."><plain>Effects of NOX2 on the degree of brain injury and functional recovery following MCAO and tPA reperfusion was assessed in young adult and aged rats </plain></SENT>
<SENT sid="2" pm="."><plain>Rats received <z:chebi fb="0" ids="2781">apocynin</z:chebi> (NOX2 inhibitor; 5 mg/kg) or saline 30 min prior to MCAO </plain></SENT>
<SENT sid="3" pm="."><plain>At 24 h following MCAO, blood-brain barrier permeability (<z:chebi fb="2" ids="33602">BBB</z:chebi>), <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, <z:hpo ids='HP_0000969'>edema</z:hpo> formation, and oxidative damage were measured </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="2781">Apocynin</z:chebi> treatment in aged rats increased mortality rate and failed to improve functional outcome, total <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, <z:hpo ids='HP_0000969'>edema</z:hpo> formation, and <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability </plain></SENT>
<SENT sid="5" pm="."><plain>Aged rats displayed increased <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability to <z:chebi fb="27" ids="17992">sucrose</z:chebi> in the contralateral hemisphere following MCAO and diminished <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity in the brain as compared to young adult rats </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that inhibition of NOX2 in the aged rat exacerbates <z:hpo ids='HP_0001297'>stroke</z:hpo> injury and diminishes functional outcome </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest age is an important factor in <z:hpo ids='HP_0001297'>stroke</z:hpo> damage and more rigorous examination of <z:chebi fb="0" ids="2781">apocynin</z:chebi> as a therapeutic agent for treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> must be done </plain></SENT>
</text></document>